🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchPhase 3 trial enrollment guide — my results so far Page 5

Phase 3 trial enrollment guide — my results so far

josh_phd_bmore Mon, Feb 23, 2026 at 12:22 PM 21 replies 1,019 viewsPage 5 of 5
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Mar 1, 2026 at 1:48 AM#21

One concrete data point for the thread. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

That is the short version; the long version is somebody else's post.

Last edited: Mar 1, 2026 at 4:48 AM
50 0NeuroNate, JessicaH_TX, KevinCompounds and 47 others
Reply Quote Save Share Report
FitDadDave
Member
534
2,678
Jul 2024
Minneapolis, MN
Mar 2, 2026 at 2:42 AM#22

Following on from Dr.SportsMedIN — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

49 24kim_atl_prep, sarah_TO, wendy_avl and 46 others
Reply Quote Save Share Report
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Mar 3, 2026 at 3:37 AM#23
stefan_berlin said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Last edited: Mar 3, 2026 at 5:37 AM
48 23Dr.NateNeph, PharmD_Rodriguez, julia.endo and 45 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Mar 4, 2026 at 4:33 AM#24
stefan_berlin said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Last edited: Mar 4, 2026 at 10:33 AM
47 22DanielChem_CHI, marco_milano, pam_columbus and 44 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Mar 5, 2026 at 5:29 AM#25
stefan_berlin said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Bookmarking. The distinction being drawn above is the one nobody else makes. I will report back once I have actually tried it.

46 21lucas_SP_BR, lisa_labSD, adam_van and 43 others
Reply Quote Save Share Report
1345

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register